Get in Touch

Global overview of launch scenario outcomes

Book a demo

Asset evaluation

Utilizing our vast analogue databases, an asset valuation is generated based on 15 parameters such as disease burden, drug benefit and your company’s pricing principles

Global Pricing Scenarios

Dynamic reference pricing models take the asset valuation through different launch scenarios. Using a variety of options and current IRP rules, you can adjust settings to see how your potential price will vary based on different scenarios.

Impact adjustor

You can now make adjustments for development and launch timelines, epidemiology, costs and discount rates to determine the impact on the assets net-present value.

Traditional pricing model comparator

Product features

Traditional IRP Model

Application of IRP rules

Traditional IRP Model

  • Pre-populated with formal referencing

Launch Success Model

  • Pre-populated with formal referencing rules with added optionality on informal rule application and programmed to search for changes in rules

Pricing data

Traditional IRP Model

  • Open field for users to insert initial launch price

Launch Success Model

  • Open field plus asset valuation-based pricing

Baseline assumptions

Traditional IRP Model

  • Regularly based on most recent launch experience

Launch Success Model

  • Setup for optimal revenue and timing

Asset valuation function

Traditional IRP Model

  • N/A

Launch Success Model

  • Asset valuation based on disease burden, clinical value and pricing 
principles and giving price range based on matched historical prices

Cumulative NPV launch scenario view

Traditional IRP Model

  • N/A

Launch Success Model

  • A risk-adjusted & discounted NPV model of revenue and costs of launch scenarios 
with selected editable variables (e.g., clinical development timeline, discount factors)

Side-by-side scenario analysis

Traditional IRP Model

  • N/A

Launch Success Model

  • Assess the timing and revenue implications of different launch scenarios along with report generation and export functions

Excel hosted

The launch success model uses the ultra-dependable framework of MS Excel to house and implement the software.

P4A’s Launch Success Model assesses asset value and launch sequencing to 
determine revenue potential.

Excel based customisable ribbon

Simplified interface with information pop-ups

Calculated price range is based on historical prices

Revenue indications

In addition to value and launch sequencing the Launch Success Model platform can augment 
your current scenario.

Using a variety of options and references, you can adjust settings to see how your potential price will vary based on different outcomes of crucial parameters.

Adjust your scenario

You can now fully understand the implications of inputs and output costs against your product development.

The Launch Success Model includes 
Phase 1-3 trial stages and market data requirements to ascertain what is needed to acquire the best price possible.

Discover Launch Success Model

Book a demo session with one of our consultants

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact